SCHEMBL17952992

SCHEMBL17952992

CC1=Cc2c(-c3ccccc3)cccc2C1CC1C(C)=Cc2c1cccc2N1c2ccccc2CC1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
ROCK1 Q13464 1/20 0.34
HSD17B10 Q99714 2/20 0.32
KDM4E B2RXH2 2/20 0.32
HPGD P15428 2/20 0.32
GLA P06280 1/20 0.32
POLB P06746 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
LMNA P02545 3/20 0.32
HTT P42858 2/20 0.32
PKM P14618 1/20 0.32
CLK1 P49759 1/20 0.32
NOTUM Q6P988 1/20 0.32
NPC1 O15118 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31
MAPK1 P28482 1/20 0.31
MAPT P10636 1/20 0.30
HTR7 P34969 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17169027 0.91 ROCK1 (0.39) ALDH1A1ROCK1HSD17B10KDM4EHPGD
SCHEMBL17952986 0.90 RXRA (0.33) HPGDPOLBNPSR1PKMHTR7
SCHEMBL17952993 0.87 ALDH1A1 (0.35) ALDH1A1ROCK1HSD17B10HPGDLMNA
SCHEMBL19336699 0.85 ALDH1A1 (0.37) ALDH1A1ROCK1HSD17B10KDM4EHPGD
SCHEMBL17952991 0.85 ROCK1 (0.35) ALDH1A1ROCK1HSD17B10KDM4EHPGD
SCHEMBL17082250 0.84 ALDH1A1 (0.39) ALDH1A1ROCK1HSD17B10KDM4EHPGD
SCHEMBL17082249 0.82 ALDH1A1 (0.38) ALDH1A1ROCK1HSD17B10LMNAHTT
SCHEMBL17952995 0.82 ROCK1 (0.35) ALDH1A1ROCK1HSD17B10KDM4EHPGD
SCHEMBL17952988 0.81 ROCK1 (0.34) ALDH1A1ROCK1HSD17B10LMNAHTT
SCHEMBL5084813 0.80 PDCD1 (0.39) ALDH1A1HSD17B10HPGDLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790240-B2 Ligand compound, a preparation method thereof, a transition metal compound, and a preparation method thereof LG CHEM, LTD. (KR) 2017-10-17 US disclosed
US-20160215004-A1 A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND, AND A PREPARATION METHOD THEREOF LG CHEM, LTD. (KR) 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160215004-A1 A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND, AND A PREPARATION METHOD THEREOF CD40LG, OSTC, TNFSF10 ALDH1A1 2895/4885ROCK1 3232/4885HSD17B10 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.